Prokidney (PROK) Revenue (2024 - 2026)

Prokidney (PROK) posted quarterly Revenue of $226000.0 for Q1 2026, down 1.74% year-over-year from $230000.0 in Q1 2025, and little changed quarter-over-quarter from $225000.0 in Q4 2025.

Prokidney (PROK) Revenue (2024 - 2026) Analysis & Trends

Prokidney (PROK) has reported Revenue for 3 consecutive years, with $226000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Revenue fell 1.74% year-over-year to $226000.0; the TTM figure through Mar 2026 stood at $889000.0 (up 190.52% YoY), while the FY2025 annual figure was $893000.0, up 1075.0% from the prior year.
  • Revenue steadied at $226000.0 in Q1 2026 per PROK's latest filing, from $225000.0 in the prior quarter.
  • Across five years, Revenue topped out at $230000.0 in Q1 2025 and bottomed at $76000.0 in Q4 2024.
  • Historically, Revenue has averaged $199166.7 across 3 years, with a median of $223000.0 in 2025.
  • Annual changes were most pronounced in 2025 — Revenue surged 196.05% — and 2026, when it retreated 1.74%.
  • Prokidney's Revenue stood at $76000.0 in 2024, then surged by 196.05% to $225000.0 in 2025, then grew by 0.44% to $226000.0 in 2026.
  • Business Quant data shows PROK's Revenue at $226000.0 in Q1 2026, $225000.0 in Q4 2025, and $217000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.56 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.71 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,001.92
7 Royalty Pharma 33.72 Bn 35.84 Bn - 674.14 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.29 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 425.49 Mn
10 Prokidney 679.95 Mn 679.95 Mn - 150,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 150,000.00
Mar 31, 2026 226,000.00
Dec 31, 2025 225,000.00
Sep 30, 2025 217,000.00
Jun 30, 2025 221,000.00
Mar 31, 2025 230,000.00
Dec 31, 2024 76,000.00